Angle Plc

Angle PLC is a medical technology company that has developed and is commercialising its Parsortix® system. This system is designed to capture circulating tumour cells from patient blood. Its primary aim is to provide insights for cancer research and clinical decision-making globally. Operating within the healthcare and diagnostics sector, Angle PLC focuses on advancing liquid biopsy technology. The company's approach aims to enable detailed analysis of captured cancer cells. This work is intended to aid researchers and clinicians in understanding and treating cancer more effectively. Stay up to date on the share price of AGL.L by adding it to your eToro watchlist. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.